0 01/04/2024 31/03/2025 2025-03-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2024-04-01 Sage Accounts Production 25.0 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 10767714 2024-04-01 2025-03-31 10767714 2025-03-31 10767714 2024-03-31 10767714 2023-04-01 2024-03-31 10767714 2024-03-31 10767714 2023-03-31 10767714 bus:RegisteredOffice 2024-04-01 2025-03-31 10767714 bus:Director1 2024-04-01 2025-03-31 10767714 core:HedgingReserve 2023-04-01 2024-03-31 10767714 core:RetainedEarningsAccumulatedLosses 2023-04-01 2024-03-31 10767714 core:HedgingReserve 2024-04-01 2025-03-31 10767714 core:RetainedEarningsAccumulatedLosses 2024-04-01 2025-03-31 10767714 core:WithinOneYear 2025-03-31 10767714 core:WithinOneYear 2024-03-31 10767714 core:ShareCapital 2025-03-31 10767714 core:ShareCapital 2024-03-31 10767714 core:HedgingReserve 2025-03-31 10767714 core:HedgingReserve 2024-03-31 10767714 core:RetainedEarningsAccumulatedLosses 2025-03-31 10767714 core:RetainedEarningsAccumulatedLosses 2024-03-31 10767714 core:ShareCapital 2023-03-31 10767714 core:HedgingReserve 2023-03-31 10767714 core:RetainedEarningsAccumulatedLosses 2023-03-31 10767714 core:PreviouslyStatedAmount core:ShareCapital 2025-03-31 10767714 bus:Director1 2024-03-31 10767714 bus:Director1 2025-03-31 10767714 bus:Director1 2023-03-31 10767714 bus:Director1 2024-03-31 10767714 bus:Director1 2023-04-01 2024-03-31 10767714 bus:SmallEntities 2024-04-01 2025-03-31 10767714 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 10767714 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 10767714 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 10767714 bus:FullAccounts 2024-04-01 2025-03-31 10767714 core:OtherReservesSubtotal 2023-03-31 10767714 core:OtherReservesSubtotal 2025-03-31 10767714 core:OtherCapitalReserve 1 2023-04-01 2024-03-31 10767714 1 2023-04-01 2024-03-31 10767714 core:OtherCapitalReserve 1 2024-04-01 2025-03-31 10767714 1 2024-04-01 2025-03-31
Company registration number: 10767714
Kyra Holdings Limited
Unaudited filleted financial statements
31 March 2025
Kyra Holdings Limited
Contents
Directors and other information
Statement of financial position
Statement of changes in equity
Notes to the financial statements
Kyra Holdings Limited
Directors and other information
Director Mr G Pashley
Company number 10767714
Registered office Lower End
Bubbenhall
Coventry
Warwickshire
CV8 3BW
Kyra Holdings Limited
Statement of financial position
31 March 2025
2025 2024
Note £ £ £ £
Current assets
Debtors 4 100 100
Investments 5 693,792 689,887
Cash at bank and in hand 15,393 10,335
_______ _______
709,285 700,322
Creditors: amounts falling due
within one year 6 ( 600,513) ( 600,413)
_______ _______
Net current assets 108,772 99,909
_______ _______
Total assets less current liabilities 108,772 99,909
_______ _______
Net assets 108,772 99,909
_______ _______
Capital and reserves
Called up share capital 100 100
Fair value reserve 61,249 57,344
Profit and loss account 47,423 42,465
_______ _______
Shareholders funds 108,772 99,909
_______ _______
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 10 October 2025 , and are signed on behalf of the board by:
Mr G Pashley
Director
Company registration number: 10767714
Kyra Holdings Limited
Statement of changes in equity
Year ended 31 March 2025
Called up share capital Fair value reserve Profit and loss account Total
£ £ £ £
At 1 April 2023 100 3,907 38,336 42,343
Profit for the year 4,129 4,129
Other comprehensive income for the year:
User defined other comprehensive income movement 1 - 53,437 - 53,437
_______ _______ _______ _______
Total comprehensive income for the year - 53,437 4,129 57,566
_______ _______ _______ _______
At 31 March 2024 and 1 April 2024 100 57,344 42,465 99,909
Profit for the year 4,958 4,958
Other comprehensive income for the year:
User defined other comprehensive income movement 1 - 3,905 - 3,905
_______ _______ _______ _______
Total comprehensive income for the year - 3,905 4,958 8,863
_______ _______ _______ _______
At 31 March 2025 100 61,249 47,423 108,772
_______ _______ _______ _______
Kyra Holdings Limited
Notes to the financial statements
Year ended 31 March 2025
1. General information
The company is a private company limited by shares, registered in England. The address of the registered office is The Manor House, Lower End, Bubbenhall, Coventry, Warwickshire, CV8 3BW.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Debtors
2025 2024
£ £
Other debtors 100 100
_______ _______
5. Investments
2025 2024
£ £
Credit Suisse portfolio investments 693,792 689,887
_______ _______
6. Creditors: amounts falling due within one year
2025 2024
£ £
Other creditors 600,513 600,413
_______ _______
7. Financial instruments
The carrying amount for each category of financial instrument is as follows:
2025 2024
£ £
Financial assets measured at fair value through profit or loss
Investments 693,792 689,887
_______ _______
Financial assets that are debt instruments measured at amortised cost
Cash at bank and in hand 15,393 10,335
_______ _______
8. Directors advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:
2025
Balance brought forward Advances /(credits) to the director Balance o/standing
£ £ £
Mr G Pashley ( 100,413) ( 100) ( 100,513)
_______ _______ _______
2024
Balance brought forward Advances /(credits) to the director Balance o/standing
£ £ £
Mr G Pashley ( 100,350) ( 63) ( 100,413)
_______ _______ _______